Elsevier

Medical Hypotheses

Volume 94, September 2016, Pages 103-107
Medical Hypotheses

Vitamin D deficiency changes the intestinal microbiome reducing B vitamin production in the gut. The resulting lack of pantothenic acid adversely affects the immune system, producing a “pro-inflammatory” state associated with atherosclerosis and autoimmunity

https://doi.org/10.1016/j.mehy.2016.07.007Get rights and content

Abstract

Study objectives

Vitamin D blood levels of 60–80 ng/ml promote normal sleep. The present study was undertaken to explore why this beneficial effect waned after 2 years as arthritic pain increased. Pantothenic acid becomes coenzyme A, a cofactor necessary for cortisol and acetylcholine production. 1950s experiments suggested a connection between pantothenic acid deficiency, autoimmune arthritis and insomnia. The B vitamins have been shown to have an intestinal bacterial source and a food source, suggesting that the normal intestinal microbiome may have always been the primary source of B vitamins. Review of the scientific literature shows that pantothenic acid does not have a natural food source, it is supplied by the normal intestinal bacteria. In order to test the hypothesis that vitamin D replacement slowly induced a secondary pantothenic acid deficiency, B100 (100 mg of all B vitamins except 100 mcg of B12 and biotin and 400 mcg of folate) was added to vitamin D supplementation.

Methods

Vitamin D and B100 were recommended to over 1000 neurology patients. Sleep characteristics, pain levels, neurologic symptoms, and bowel complaints were recorded by the author at routine appointments.

Results

Three months of vitamin D plus B100 resulted in improved sleep, reduced pain and unexpected resolution of bowel symptoms. These results suggest that the combination of vitamin D plus B100 creates an intestinal environment that favors the return of the four specific species, Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria that make up the normal human microbiome.

Hypotheses

1) Seasonal fluctuations in vitamin D levels have normally produced changes in the intestinal microbiome that promoted weight gain in winter. Years of vitamin D deficiency, however, results in a permanently altered intestinal environment that no longer favors the “healthy foursome”. 2) Humans have always had a commensal relationship with their intestinal microbiome. We supplied them vitamin D, they supplied us B vitamins. 3) The four species that make up the normal microbiome are also commensal, each excretes at least one B vitamin that the other three need but cannot make. 4) Improved sleep and more cellular repairs eventually depletes body stores of pantothenic acid, causing reduced cortisol production, increased arthritic pain and widespread “pro-inflammatory” effects on the immune system. 5) Pantothenic acid deficiency also decreases available acetylcholine, the neurotransmitter used by the parasympathetic nervous system. Unopposed, increased sympathetic tone then produces hypertension, tachycardia, atrial arrhythmias and a “hyper-adrenergic” state known to predispose to heart disease and stroke.

Introduction

Vitamin D deficiency is a global epidemic and has been linked to numerous diseases including sleep disorders [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11]. There has been a parallel change in the human intestinal microbiome thought to be linked to the increasing incidence of obesity, hypertension, high cholesterol, autoimmune disorders, and atherosclerotic heart disease [12], [13], [14], [15], [16], [17]. Recent reports documenting that 7 of the 8 B vitamins have a colonic bacterial source and a food source suggest that a population with the “wrong” intestinal microbiome might have unexpected B vitamin deficiencies, unrelated to food sources, that might play a role in the etiology of those diseases [18].

In 2012 we reported a successful, uncontrolled trial of vitamin D supplementation (in doses to maintain a blood level of 60–80 ng/ml) as treatment for sleep disorders [1]. This current report documents the continued treatment of the same patient population for another four years. Despite maintaining a vitamin D blood level of 60–80 ng/ml, most patients’ sleep complaints began to return by the end of the second year. Because of 1950s reports of insomnia produced by pantothenic acid (B5) deficiency B100 (a non-proprietary over-the-counter B complex of 100 mg of thiamine, riboflavin, niacin, pantothenic acid, pyridoxine, 100 mcg of cyanocobalamin, 100 mcg biotin, and 400 mcg of folic acid) was added to the vitamin D regimen [19], [20], [21], [22]. Vitamin B5 is needed to make Coenzyme A, a metabolic cofactor used in over one hundred metabolic processes, including the production of cortisol, melatonin and acetylcholine [23], [24], [25]. Acetylcholine is a neurotransmitter responsible for our level of alertness during the day as well as the normal completion of rapid eye movement (REM) sleep at night [26], [27], [28]. The addition of B100 led to rapid improvement in sleep as well as an unexpected resolution of irritable bowel syndrome (IBS) symptoms.

Section snippets

Methods

Over 1000 neurology patients took part in an uncontrolled treatment trial with a regimen of vitamin D and B100 for sleep disorders. Patients with primary brain cancer, amyotrophic lateral sclerosis, or Alzheimer’s disease were excluded. Occasional patients presented for primary sleep disorders such as insomnia or sleep apnea, but most came for neurologic complaints of headache, vertigo, epilepsy, tics, pain, multiple sclerosis, neuropathy, Parkinson’s disease, tremor, dystonia, cerebellar

Results

Vitamin D replacement, in combination with a specific, high dose B vitamin supplementation (B100 or B50, 1/2 of B100) brought about complete resolution of all IBS symptoms in the majority of patients by the end of three months. This included many patients who had been constipated since childhood. The high dose B supplement was stopped at three months, the vitamin D level was maintained at 60–80 ng/ml, and patients observed for a maximum of three years had no return of IBS symptoms. The

The changed intestinal microbiome

There is a pandemic of the “wrong” intestinal microbiome, the cause of which is unknown. The current treatments; probiotics and fecal transplant, are intended to provide the “missing” bacterial species but they are only partially successful [12], [13], [14], [15], [16], [17]. Observations regarding the negative effects of abnormal intestinal flora go far beyond the bowel symptomatology of IBS. There are reports linking the “wrong” intestinal flora to hypertension, heart disease, high

Conclusion

I hypothesize that the parallel epidemics of abnormal sleep and abnormal intestinal microbiome are linked to one another through vitamin D deficiency. Proper supplemental doses of vitamin D plus all 8 B vitamins appears to return the intestinal microbiome to normal in three months. Reinstating the normal microbiome not only treats IBS symptoms, it returns the supply of B vitamins to their natural daily doses. The B vitamins are neither “good for us” nor “unnecessary”; they are good for the

References (64)

  • M. Quick et al.

    The sodium/multivitamin transporter: a multipotent system with therapeutic implications

    Vitam Horm

    (2015)
  • D.M. Davydov et al.

    Baroreflex mechanisms in irritable bowel syndrome: Part I. Traditional indices

    Physiol Behav

    (2016)
  • D.H. Alpers

    Absorption and blood/cellular transport of folate and cobalamin: pharmacokinetic and physiological considerations

    Biochimie

    (2016)
  • J. Massa et al.

    Vitamin D and actigraphic sleep outcomes in older community dwelling men: the MrOS sleep study

    Sleep

    (2015)
  • J.A. Reynolds et al.

    Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus

    Sci Rep

    (2016)
  • C.C. Gao et al.

    Severe vitamin D deficiency increases the risk for moderate to severe disease activity in Chinese patients with SLE

    Lupus

    (2016)
  • S. Azrielant et al.

    “Eppur Si Muove”: vitamin D is essential in preventing and modulating SLE

    Lupus

    (2016)
  • Z. Lin et al.

    The roles of vitamin D and its analogs in inflammatory diseases

    Curr Top Med Chem

    (2016)
  • V. Bruzzese et al.

    Vitamin D deficiency in patients with either rheumatic diseases or inflammatory bowel diseases on biologic therapy

    Intern Emerg Med

    (2016)
  • J. Lin et al.

    Serum vitamin D level and rheumatoid arthritis disease activity: review and meta-analysis

    PLoS One

    (2016)
  • E. Belen et al.

    Low-level vitamin D is associated with atrial fibrillation in patients with chronic heart failure

    Adv Clin Exp Med

    (2016)
  • X. Xiao et al.

    Vitamin D deficiency and related risk factors in patients with diabetic nephropathy

    J Int Med Res

    (2016)
  • S.H. Kim et al.

    Relationship between serum vitamin D levels and symptoms of depression in stroke patients

    Ann Rehabil Med

    (2016)
  • P.B. Eckburg

    Diversity of the human intestinal microbial flora

    Science

    (2005)
  • J.J. Faith et al.

    The long-term stability of the human gut microbiota

    Science

    (2013)
  • A.L. Kau et al.

    Human nutrition, the gut microbiome, and immune system; envisioning the future

    Nature

    (2011)
  • S. Frosali et al.

    How the intricate interaction among toll-like receptors microbiota and intestinal immunity can influence gastrointestinal pathology

    J Immunol Res

    (2015)
  • J.L. Griffin et al.

    Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics

    Circ Cardiovasc Genet

    (2015)
  • H. Said

    Intestinal absorption of water-soluble vitamins in health and disease

    Biochem J

    (2011)
  • R.E. Hodges et al.

    Pantothenic acid deficiency in man

    J Clin Invest

    (1958)
  • R.E. Hodges et al.

    Human pantothenic acid deficiency produced by omega-methyl pantothenic acid

    J Clin Invest

    (1959)
  • W.B. Bean et al.

    Pantothenic acid deficiency induced in human subjects

    J Clin Invest

    (1955)
  • Cited by (0)

    View full text